Candidates must possess a Master’s degree in Life Sciences, Biochemistry, Biotechnology, Zoology, Bioinformatics, or allied areas with at least 55% marks from a recognized university.
Post-Graduation in life science. Graduate degree in science with PG Diploma in Clinical Research. Experience of one year in relevant filed is desirable.
M.Tech. in Nanoscience and Nanotechnology, Biotechnology, Biochemical Engineering, Materials Science or M.Sc. in Chemistry, Biochemistry, Biotechnology, Microbiology. IIT-BHU
postgraduate degree in Zoology, Biochemistry, Biotechnology, Life Science or a related field with the research experience after completing PG or Ph.D. research experience in molecular biology techniques and animal handling.
Applicants should hold a Ph.D. degree and should have research publications in cell biology and, or molecular genetics, developmental biology, preferably using Drosophila model. Those who have submitted their doctoral thesis and are awaiting results may also apply.
An open–label phase II trial evaluating the activity and safety of JDQ443 single agent as first-line treatment for patients with locally advanced or metastatic KRAS G12Cmutated non-small cell lung cancer
B.Pharm OR D.Pharm. Experience in Dispensary / Pharmacy of the Hospital having minimum 200 beds. Candidate should be prepared to work in shift duties, including night shift. Registration with State Pharmacy Council with duly allotted Registration Number is mandatory.
Promote pharma product portfolio to healthcare professionals and institutions. Develop and maintain strong relationships with doctors, pharmacists, and key opinion leaders. Achieve sales targets and ensure market growth in the assigned territory.